ISTANBUL German biotech firm BioNTech reported a loss of €665.3 million ($721 million) in 2024, as demand for its COVID-19 vaccines fell, according to the company's financial results report on Monday. The company, which posted a €930.3 million profit in 2023, failed to make a profit in a fiscal year for the first time since 2019. BioNTech's revenues decreased by 27% last year compared to the previous year to €2.75 billion. "The decrease in revenues was primarily driven by lower sales of the

Tag-uri: Coronavirus